Immunoglobulin G2, Anti-(Human Cd19 (Antigen)) (Synthetic Human Monoclonal Medi-551 Heavy Chain), Disulfide With Synthetic Human Monoclonal Medi-551 .Kappa.-Chain, Dimer
Encephalitis
University of Utahmonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Encephalitis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Lenalidomide St. Joseph's Hospital and Medical Center, Phoenix | Phase 2 | NR |
Same molecule, other indications
Immunoglobulin G2, Anti-(Human Cd19 (Antigen)) (Synthetic Human Monoclonal Medi-551 Heavy Chain), Disulfide With Synthetic Human Monoclonal Medi-551 .Kappa.-Chain, Dimer is also rated in:
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
B
Indicative · Phase 2
57 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →